Fig. 2From: Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics dataPredictive power of subpathway signatures across five cancer-drug response datasets from TCGA, including a BLCA-cisplatin, b BLCA-gemcitabine, c PAAD-gemcitabine, d STAD-fluorouracil and e LGG-temozolomideBack to article page